IP Library Granted Patent US 12,091,718
Granted Patent B2
US 12,091,718 · App. 18/049,805 · Granted Sep 17, 2024

Genetically encoded biosensors for detection of polyketides

Inventors: Gavin J. Williams (Raleigh, NC); Christian Kasey (Raleigh, NC); Yiwei Li (Raleigh, NC)
Assignee: North Carolina State University
C12Q1/6897C07K14/245C12N15/09
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,091,718
App. No.
18/049,805
Granted
Sep 17, 2024
Kind
B2
Abstract

The present disclosure relates to high-throughput detection of polyketides using genetically encoded biosensors.

Claims (17)

1. A biosensor system comprising:

a nucleic acid encoding a genetically modified MphR gene sequence, wherein the nucleic acid comprises at least one genetic mutation when compared to the wild-type MphR gene sequence; and

a reporter gene whose transcription is under the control of a promoter region which is regulated by a MphR transcription factor;

wherein the MphR genetic mutation encodes an amino acid change selected from T17R, T27G, T49I, 065M, T27A, M59E, M59S, R22H, K35N, T49I, L89V, D98N, E109D, R122T, K132N, A151T, H184Q, or a combination thereof, in the ligand binding domain.

2. The biosensor system of claim 1 , wherein the nucleic acid encoding the genetically modified MphR gene sequence and the reporter gene are located on one recombinant DNA vector.

3. The biosensor system of claim 1 , wherein the reporter gene is a gene coding for chloramphenicol acetyltransferase, beta-galactosidase, luciferase or green fluorescent protein (GFP).

4. The biosensor system of claim 3 , wherein the reporter gene is a gene coding for green fluorescent protein (GFP).

5. The biosensor system of claim 1 , wherein the mutation confers improved sensitivity for detecting erythromycin A.

6. The biosensor system of claim 1 , wherein the mutation confers improved selectivity for detecting erythromycin A in comparison to other polyketides.

7. A genetically modified host cell comprising:

a nucleic acid encoding the biosensor of claim 1 .

8. A method for detecting a polyketide, comprising:

introducing into a cell:

i. a nucleic acid encoding a genetically modified MphR gene sequence, wherein the nucleic acid comprises at least one genetic mutation when compared to the wild-type MphR gene sequence; and

ii. a reporter gene whose transcription is under the control of a promoter region which is regulated by a MphR transcription factor; and

detecting the polyketide based on the differential expression of the reporter gene in comparison to a cell comprising a wild-type MphR gene sequence;

wherein the MphR genetic mutation encodes an amino acid change selected from T17R, T27G, T49I, 065M, T27A, M59E, M59S, R22H, K35N, T49I, L89V, D98N, E109D, R122T, K132N, A151T, H184Q, or a combination thereof, in the ligand binding domain.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 3, 2023
From: NORTH CAROLINA STATE UNIVERSITY RALEIGH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 064479/0128 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2023
From: WILLIAMS, GAVIN J.; KASEY, CHRISTIAN; LI, YIWEI
To: NORTH CAROLINA STATE UNIVERSITY
Reel/Frame 062522/0875 →
Continuity (3)
Continuation 16099749
Provisional Application 62334204 · May 10, 2016
Related Publication 20230323481A1 · Oct 12, 2023